BRIEF-Pharmstandart receives controlling stake in MasterPlazma

<span id="midArticle_start"/>May 28Pharmstandart :

<span id="midArticle_0"/>* Says has received 52 pct stake in MasterPlazma LLCSourcetext: bit.ly/1HygTUZ

<span id="midArticle_1"/> <span class="first-article-divide"/>Further company coverage:

<span id="midArticle_2"/> <span class="second-article-divide"/> <span class="third-article-divide"/>(Gdynia Newsroom)

<span id="midArticle_3"/>

via Smart Health Shop Forum http://ift.tt/1dAfK8e